Print Page     Close Window     

SEC Filings / Section 16 Reports

DEF 14A
BECTON DICKINSON & CO filed this Form DEF 14A on 12/03/2018
Entire Document
 

Securities owned by directors and management
The following table sets forth as of December 1, 2018 information concerning the beneficial ownership of BD common stock by (i) each director and nominee, (ii) the executive officers named in the Summary Compensation Table on page 37, and (iii) all directors and executive officers as a group. Each person has the sole power to vote and dispose of the shares he or she beneficially owns.
BD has a policy that prohibits directors, officers and employees from pledging BD shares or engaging in transactions that are intended to hedge against the economic risk of owning BD shares. None of BD’s directors or executive officers has pledged or hedged against any of the shares listed.
BD COMMON STOCK
 
Name
 
Amount and
nature of
beneficial ownership(1)
 
Percentage
of class
Catherine M. Burzik
 
8,751

 
 
*
R. Andrew Eckert
 
2,538

 
 
*
Vincent A. Forlenza
 

 
 
*
Claire M. Fraser
 
21,844

 
 
*
Jeffrey W. Henderson
 
399

 
 
*
Christopher Jones
 
20,918

 
 
*
Marshall O. Larsen
 
23,677

 
 
*
Patrick K. Kaltenbach
 
0

 
 
*
Samrat S. Khichi
 

 
 
*
Gary A. Mecklenburg
 
32,754

 
 
*
David F. Melcher
 
5,245

 
 
*
Willard J. Overlock, Jr.
 
48,475

 
 
*
Thomas E. Polen
 

 
 
*
Claire Pomeroy
 
6,297

 
 
*
Christopher R. Reidy
 

 
 
*
Rebecca W. Rimel
 
10,054

 
 
*
Timothy M. Ring
 
94,921

 
 
*
Bertram L. Scott
 
41,638

 
 
*
Directors and executive officers as a group (24 persons)
 

 
 
x.x%
_______________________________________
*
Represents less than 1% of the outstanding BD common stock.
(1)
Includes (a) shares held directly, (b) with respect to executive officers, indirect interests in BD common stock held under the BD 401(k) Plan, GSIP and the Restoration Plan, and (c) with respect to the non-management directors, indirect interests in BD common stock held under the Directors’ Deferral Plan. Additional information on certain of these plans appears on page 5. Includes shares under outstanding equity compensation awards that executive officers may acquire within 60 days, as follows: Mr. Forlenza, x,xxx,xxx shares; Mr. Khichi, xx,xxx shares; Mr. Polen, xx,xxx shares; and Mr. Reidy, xx,xxx shares. Also includes, with respect to each non-management director, shares issuable under restricted stock units as follows: Ms. Burzik, 4,896 shares; Mr. Eckert, 950 shares; Dr. Fraser, 17,893 shares; Mr. Henderson, 384 shares; Mr. Jones, 10,688 shares; Mr. Larsen, 15,969 shares; Mr. Mecklenburg, 21,743 shares; Mr. Melcher, 2,228 shares; Mr. Overlock, 24,873 shares; Dr. Pomeroy, 2,346 shares; Ms. Rimel, 6,151 shares; Mr. Ring, 1,006 and Mr. Scott, 23,280 shares. The above table does not reflect the grant of restricted stock units that the persons elected as director at the 2019 Annual Meeting will receive, as the amount of these grants cannot be determined at this time. See “Non-management directors’ compensation—Equity award” on page 12.

4